349 related articles for article (PubMed ID: 21602892)
1. Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOR.
Rosner M; Hengstschläger M
Oncogene; 2011 Nov; 30(44):4509-22. PubMed ID: 21602892
[TBL] [Abstract][Full Text] [Related]
2. p70 S6K1 nuclear localization depends on its mTOR-mediated phosphorylation at T389, but not on its kinase activity towards S6.
Rosner M; Schipany K; Hengstschläger M
Amino Acids; 2012 Jun; 42(6):2251-6. PubMed ID: 21710263
[TBL] [Abstract][Full Text] [Related]
3. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.
Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R
J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic receptor-mediated activation of p70 S6 kinase 1 (S6K1) in 1321N1 astrocytoma cells: permissive role of phosphoinositide 3-kinase.
Tang X; Wang L; Proud CG; Downes CP
Biochem J; 2003 Aug; 374(Pt 1):137-43. PubMed ID: 12747804
[TBL] [Abstract][Full Text] [Related]
5. Regulation and localization of ribosomal protein S6 kinase 1 isoforms.
Kim D; Akcakanat A; Singh G; Sharma C; Meric-Bernstam F
Growth Factors; 2009 Feb; 27(1):12-21. PubMed ID: 19085255
[TBL] [Abstract][Full Text] [Related]
6. Akt regulates nuclear/cytoplasmic localization of tuberin.
Rosner M; Freilinger A; Hengstschläger M
Oncogene; 2007 Jan; 26(4):521-31. PubMed ID: 16862180
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
[TBL] [Abstract][Full Text] [Related]
8. The S6K protein family in health and disease.
Tavares MR; Pavan IC; Amaral CL; Meneguello L; Luchessi AD; Simabuco FM
Life Sci; 2015 Jun; 131():1-10. PubMed ID: 25818187
[TBL] [Abstract][Full Text] [Related]
9. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
Fang CX; Yang X; Sreejayan N; Ren J
Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of melanogenesis by phospholipase D1 through mTOR/p70 S6 kinase 1 signaling in mouse B16 melanoma cells.
Ohguchi K; Banno Y; Nakagawa Y; Akao Y; Nozawa Y
J Cell Physiol; 2005 Dec; 205(3):444-51. PubMed ID: 15895362
[TBL] [Abstract][Full Text] [Related]
11. Interferon beta augments tuberous sclerosis complex 2 (TSC2)-dependent inhibition of TSC2-null ELT3 and human lymphangioleiomyomatosis-derived cell proliferation.
Goncharova EA; Goncharov DA; Chisolm A; Spaits MS; Lim PN; Cesarone G; Khavin I; Tliba O; Amrani Y; Panettieri RA; Krymskaya VP
Mol Pharmacol; 2008 Mar; 73(3):778-88. PubMed ID: 18094073
[TBL] [Abstract][Full Text] [Related]
12. The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.
Nobukini T; Thomas G
Novartis Found Symp; 2004; 262():148-54; discussion 154-9, 265-8. PubMed ID: 15562827
[TBL] [Abstract][Full Text] [Related]
13. Nutrient sensing in the mTOR/S6K1 signalling pathway.
Gulati P; Thomas G
Biochem Soc Trans; 2007 Apr; 35(Pt 2):236-8. PubMed ID: 17371247
[TBL] [Abstract][Full Text] [Related]
14. Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).
Rolfe M; McLeod LE; Pratt PF; Proud CG
Biochem J; 2005 Jun; 388(Pt 3):973-84. PubMed ID: 15757502
[TBL] [Abstract][Full Text] [Related]
15. Different cytoplasmic/nuclear distribution of S6 protein phosphorylated at S240/244 and S235/236.
Rosner M; Fuchs C; Dolznig H; Hengstschläger M
Amino Acids; 2011 Feb; 40(2):595-600. PubMed ID: 20625781
[TBL] [Abstract][Full Text] [Related]
16. hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase.
Byfield MP; Murray JT; Backer JM
J Biol Chem; 2005 Sep; 280(38):33076-82. PubMed ID: 16049009
[TBL] [Abstract][Full Text] [Related]
17. Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase/Src and mTOR pathways.
Marin TM; Clemente CF; Santos AM; Picardi PK; Pascoal VD; Lopes-Cendes I; Saad MJ; Franchini KG
Circ Res; 2008 Oct; 103(8):813-24. PubMed ID: 18757826
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase.
Shima H; Pende M; Chen Y; Fumagalli S; Thomas G; Kozma SC
EMBO J; 1998 Nov; 17(22):6649-59. PubMed ID: 9822608
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation.
Lee SJ; Yang EK; Kim SG
Mol Pharmacol; 2006 Jul; 70(1):415-25. PubMed ID: 16611854
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma.
Wan X; Mendoza A; Khanna C; Helman LJ
Cancer Res; 2005 Mar; 65(6):2406-11. PubMed ID: 15781656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
